PTCT
PTC THERAPEUTICS, INC.
Latest Form 4:Sale$912KbySCHMERTZLER MICHAEL (Director) · filed Aug 28, 2026
PTC THERAPEUTICS, INC. (PTCT) has 90 SEC Form 4 filings (356 transaction rows) in the rolling window, disclosed by 14 distinct insiders. Most recent filing: Aug 28, 2026.
The most active filer is EXEC. VP AND CLO Boulding Mark Elliott with 20 filings. Insiders have net sold $27.7M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Matthew Klein
- Employees:939
- HQ:Warren, NJ, US
- IPO:2013-06-20
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$68.7M
reported sales (SEC code S)
Unique Insiders
14
in the rolling window
Market Cap
$5.8B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 12,500 | $912K | Aug 28 | SEC ↗ | |
| Director | Sale | 12,500 | $895K | Aug 28 | SEC ↗ | |
SCHMERTZLER MICHAELFirst filing | Director | Sale | 12,500 | $917K | Aug 21 | SEC ↗ |
SCHMERTZLER MICHAELFirst filing | Director | Sale | 12,500 | $889K | Aug 21 | SEC ↗ |
| EXEC. VP AND CLO | Sale | 2,813 | $204K | Aug 19 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 10,292 | $706K | Aug 6 | SEC ↗ | |
Gravier PierreFirst in 5 months | CHIEF FINANCIAL OFFICER | Sale | 3,494 | $281K | Jul 16 | SEC ↗ |
Smith Mary L.First filing | Director | Sale | 15,834 | $1.4M | Jul 13 | SEC ↗ |
| CHIEF TECHNICAL OPS OFFICER | Sale | 2,464 | $222K | Jul 13 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 5,079 | $432K | Jul 8 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 22,161 | $1.9M | Jul 8 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 24,613 | $2.2M | Jul 8 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 8,130 | $693K | Jun 30 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 5,323 | $453K | Jun 26 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 20,960 | $1.8M | Jun 26 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 23,749 | $1.9M | Jun 24 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 10,462 | $823K | Jun 22 | SEC ↗ | |
Utter Christine MarieFirst in 4 months | SVP, CHIEF ACCOUNTING OFFICER | Sale | 19,686 | $1.5M | Jun 22 | SEC ↗ |
Pauwels EricFirst in 4 months | CHIEF BUSINESS OFFICER | Sale | 21,277 | $1.6M | Jun 12 | SEC ↗ |
| EXEC. VP AND CLO | Sale | 2,812 | $203K | May 19 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 12,572 | $917K | May 15 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 3,540 | $280K | May 12 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 2,850 | $202K | Apr 23 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 2,265 | $157K | Apr 8 | SEC ↗ | |
| EVP & CHIEF MEDICAL OFFICER | Sale | 829 | $56K | Apr 6 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 52,003 | $3.6M | Apr 3 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 2,662 | $171K | Mar 13 | SEC ↗ | |
| Director | Sale | 15,167 | $1.1M | Mar 12 | SEC ↗ | |
| EVP & CHIEF MEDICAL OFFICER | Sale | 10,000 | $634K | Mar 9 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 3,989 | $253K | Mar 9 | SEC ↗ | |
| Director | Sale | 6,333 | $401K | Mar 9 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 3,019 | $210K | Feb 23 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 3,121 | $216K | Feb 20 | SEC ↗ | |
| SVP, CHIEF ACCOUNTING OFFICER | Sale | 2,494 | $173K | Feb 20 | SEC ↗ | |
| CHIEF BUSINESS OFFICER | Sale | 3,019 | $209K | Feb 20 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 7,371 | $511K | Feb 20 | SEC ↗ | |
| EVP & CHIEF MEDICAL OFFICER | Sale | 2,484 | $172K | Feb 20 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 2,992 | $208K | Feb 20 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 2,813 | $195K | Feb 19 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 3,081 | $214K | Feb 19 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 4,033 | $309K | Jan 12 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 2,314 | $180K | Jan 12 | SEC ↗ | |
| CHIEF BUSINESS OFFICER | Sale | 4,602 | $352K | Jan 12 | SEC ↗ | |
| CHIEF BUSINESS OFFICER | Sale | 1,722 | $133K | Jan 12 | SEC ↗ | |
| CHIEF BUSINESS OFFICER | Sale | 1,024 | $81K | Jan 12 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 940 | $72K | Jan 12 | SEC ↗ | |
| EVP & CHIEF MEDICAL OFFICER | Sale | 866 | $66K | Jan 12 | SEC ↗ | |
| SVP, CHIEF ACCOUNTING OFFICER | Sale | 1,034 | $79K | Jan 12 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 2,514 | $192K | Jan 12 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 1,739 | $134K | Jan 8 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 4,879 | $378K | Jan 8 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 1,333 | $103K | Jan 8 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 1,078 | $84K | Jan 8 | SEC ↗ | |
| CHIEF BUSINESS OFFICER | Sale | 1,789 | $138K | Jan 8 | SEC ↗ | |
| CHIEF BUSINESS OFFICER | Sale | 1,352 | $105K | Jan 8 | SEC ↗ | |
Golden Lee ScottFirst filing | EVP & CHIEF MEDICAL OFFICER | Sale | 1,340 | $103K | Jan 8 | SEC ↗ |
Golden Lee ScottFirst filing | EVP & CHIEF MEDICAL OFFICER | Sale | 642 | $50K | Jan 8 | SEC ↗ |
| CHIEF EXECUTIVE OFFICER | Sale | 5,149 | $396K | Jan 8 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 3,016 | $234K | Jan 8 | SEC ↗ | |
Utter Christine MarieFirst filing | SVP, CHIEF ACCOUNTING OFFICER | Sale | 1,381 | $106K | Jan 8 | SEC ↗ |
Utter Christine MarieFirst filing | SVP, CHIEF ACCOUNTING OFFICER | Sale | 1,235 | $96K | Jan 8 | SEC ↗ |
Gravier PierreFirst filing | CHIEF FINANCIAL OFFICER | Sale | 2,139 | $165K | Jan 8 | SEC ↗ |
| EXEC. VP AND CLO | Sale | 2,266 | $171K | Jan 6 | SEC ↗ | |
| Director | Sale | 734 | $56K | Jan 6 | SEC ↗ | |
STEELE GLENN JR MD PHDFirst filing | Director | Sale | 12,000 | $916K | Jan 6 | SEC ↗ |
| CHIEF EXECUTIVE OFFICER | Sale | 8,089 | $620K | Jan 2 | SEC ↗ | |
| CHIEF BUSINESS OFFICER | Sale | 20,508 | $1.6M | Dec 23 | SEC ↗ | |
Pauwels EricFirst in 3 months | CHIEF BUSINESS OFFICER | Sale | 40,190 | $3.0M | Dec 19 | SEC ↗ |
Pauwels EricFirst in 3 months | CHIEF BUSINESS OFFICER | Sale | 3,202 | $240K | Dec 19 | SEC ↗ |
| Director | Sale | 733 | $58K | Dec 5 | SEC ↗ | |
Klein Matthew B.First filing | CHIEF EXECUTIVE OFFICER | Sale | 3,428 | $271K | Dec 3 | SEC ↗ |
| CHIEF TECHNICAL OPS OFFICER | Sale | 71,928 | $6.0M | Nov 26 | SEC ↗ | |
| Insider | Sale | 11,801 | $946K | Nov 26 | SEC ↗ | |
| Insider | Sale | 14,199 | $1.2M | Nov 26 | SEC ↗ | |
| CHIEF TECHNICAL OPS OFFICER | Sale | 35,572 | $2.9M | Nov 26 | SEC ↗ | |
| Director | Sale | 10,000 | $795K | Nov 25 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 2,812 | $214K | Nov 19 | SEC ↗ | |
| Director | Sale | 7,333 | $546K | Nov 14 | SEC ↗ | |
| Director | Sale | 15,666 | $1.1M | Oct 31 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 3,375 | $214K | Oct 9 | SEC ↗ | |
| Insider | Sale | 25,562 | $1.7M | Oct 7 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 22,655 | $1.5M | Oct 7 | SEC ↗ | |
| EXEC. VP AND CLO | Sale | 2,266 | $147K | Oct 7 | SEC ↗ | |
Almstead Neil GregoryFirst filing | CHIEF TECHNICAL OPS OFFICER | Sale | 55,000 | $3.6M | Oct 7 | SEC ↗ |
| Director | Sale | 12,000 | $780K | Oct 7 | SEC ↗ | |
Reeve EmmaFirst filing | Director | Sale | 15,705 | $934K | Sep 16 | SEC ↗ |
Boulding Mark ElliottFirst filing | EXEC. VP AND CLO | Sale | 22,664 | $1.4M | Sep 15 | SEC ↗ |
Boulding Mark ElliottFirst filing | EXEC. VP AND CLO | Sale | 24,585 | $1.5M | Sep 15 | SEC ↗ |
SOUTHWELL DAVID PFirst filing | Director | Sale | 12,000 | $700K | Sep 11 | SEC ↗ |
Pauwels EricFirst filing | CHIEF BUSINESS OFFICER | Sale | 39,850 | $2.3M | Sep 9 | SEC ↗ |
Jacobson Allan StevenFirst filing | Director | Sale | 1,667 | $84K | Sep 2 | SEC ↗ |
Related companies
PTC THERAPEUTICS, INC. is in the Healthcare sector.